Real-time enrollment status for this medulloblastoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 9:40 PM UTC
| NCT Number | NCT05382338 |
| Recruiting Status | Recruiting |
| Condition | Medulloblastoma |
| Phase | PHASE3 |
| Target Enrollment | 225 participants |
| Active Locations | 104 sites in the US |
| Sponsor | Children's Oncology Group |
| Last Updated on CT.gov | July 16, 2026 (2 days ago) |
As of July 18, 2026: Clinical trial NCT05382338 is currently recruiting participants. This phase3 study for medulloblastoma is actively seeking new participants at 104 locations across the United States. The study is sponsored by Children's Oncology Group. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05382338 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 104 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05382338 was last updated 2 days ago (July 16, 2026). HelloStudys verifies this status automatically.